Filed: 5/12/2023ACC: 0000935836-23-000397
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $298.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$298.17M
Total AUM (reported)
49.31M
Total Shares
Allocation by class
COM$144.58M48.5%
SPONSORED ADS$91.53M30.7%
SPON ADR$30.23M10.1%
COM NEW$28.86M9.7%
NOTE 2.500% 9/1$2.97M1.0%
Portfolio Concentration
Top 3$149.21M50.0%
4–10$107.46M36.0%
11–25$41.50M13.9%
Top 3 weight
50.0%
Top 10 weight
86.1%
Voting Authority Distribution
Total shares with voting rights: 49.31M
Sole
Full voting authority
49.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
AMRYT PHARMA PLC - SPNR ADR
SOLEShares6.28M
TypeSH
Market value$91.53M
30.70%
Sole
6.28M
Shared
0.00
None
0.00
GALAPAGOS NV-SPON ADR
SOLEShares782.29K
TypeSH
Market value$30.23M
10.14%
Sole
782.29K
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares6.54M
TypeSH
Market value$27.45M
9.21%
Sole
6.54M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares7.66M
TypeSH
Market value$25.36M
8.51%
Sole
7.66M
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares279.08K
TypeSH
Market value$24.86M
8.34%
Sole
279.08K
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares8.64M
TypeSH
Market value$14.08M
4.72%
Sole
8.64M
Shared
0.00
None
0.00
MAXCYTE INC
SOLEShares2.71M
TypeSH
Market value$13.40M
4.49%
Sole
2.71M
Shared
0.00
None
0.00
THIRD HARMONIC BIO INC
SOLEShares3.13M
TypeSH
Market value$12.90M
4.33%
Sole
3.13M
Shared
0.00
None
0.00
ATYR PHARMA INC
SOLEShares4.83M
TypeSH
Market value$10.13M
3.40%
Sole
4.83M
Shared
0.00
None
0.00
XOMA CORP
SOLEShares318.10K
TypeSH
Market value$6.72M
2.25%
Sole
318.10K
Shared
0.00
None
0.00
CASTLE BIOSCIENCES INC
SOLEShares292.87K
TypeSH
Market value$6.65M
2.23%
Sole
292.87K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares701.53K
TypeSH
Market value$6.48M
2.17%
Sole
701.53K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares3.09M
TypeSH
Market value$5.93M
1.99%
Sole
3.09M
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares578.79K
TypeSH
Market value$4.90M
1.64%
Sole
578.79K
Shared
0.00
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares416.52K
TypeSH
Market value$4.09M
1.37%
Sole
416.52K
Shared
0.00
None
0.00
APOLLO ENDOSURGERY INC
SOLEShares370K
TypeSH
Market value$3.67M
1.23%
Sole
370K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares132K
TypeSH
Market value$2.97M
1.00%
Sole
132K
Shared
0.00
None
0.00
EXAGEN INC
SOLEShares1.04M
TypeSH
Market value$2.52M
0.85%
Sole
1.04M
Shared
0.00
None
0.00
ATEA PHARMACEUTICALS INC
SOLEShares684.51K
TypeSH
Market value$2.29M
0.77%
Sole
684.51K
Shared
0.00
None
0.00
SCYNEXIS INC
SOLEShares450K
TypeSH
Market value$1.35M
0.45%
Sole
450K
Shared
0.00
None
0.00
CONFORMIS INC
SOLEShares402.65K
TypeSH
Market value$648.3K
0.22%
Sole
402.65K
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares1K
TypeSH
Market value$1.3K
<0.01%
Sole
1K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMRYT PHARMA PLC - SPNR ADRSOLE | SPONSORED ADS | 6.28M | SH | $91.53M 30.70% | 6.28M | 0.00 | 0.00 |
GALAPAGOS NV-SPON ADRSOLE | SPON ADR | 782.29K | SH | $30.23M 10.14% | 782.29K | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 6.54M | SH | $27.45M 9.21% | 6.54M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 7.66M | SH | $25.36M 8.51% | 7.66M | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 279.08K | SH | $24.86M 8.34% | 279.08K | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 8.64M | SH | $14.08M 4.72% | 8.64M | 0.00 | 0.00 |
MAXCYTE INCSOLE | COM | 2.71M | SH | $13.40M 4.49% | 2.71M | 0.00 | 0.00 |
THIRD HARMONIC BIO INCSOLE | COM | 3.13M | SH | $12.90M 4.33% | 3.13M | 0.00 | 0.00 |
ATYR PHARMA INCSOLE | COM NEW | 4.83M | SH | $10.13M 3.40% | 4.83M | 0.00 | 0.00 |
XOMA CORPSOLE | COM NEW | 318.10K | SH | $6.72M 2.25% | 318.10K | 0.00 | 0.00 |
CASTLE BIOSCIENCES INCSOLE | COM | 292.87K | SH | $6.65M 2.23% | 292.87K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 701.53K | SH | $6.48M 2.17% | 701.53K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 3.09M | SH | $5.93M 1.99% | 3.09M | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 578.79K | SH | $4.90M 1.64% | 578.79K | 0.00 | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 416.52K | SH | $4.09M 1.37% | 416.52K | 0.00 | 0.00 |
APOLLO ENDOSURGERY INCSOLE | COM | 370K | SH | $3.67M 1.23% | 370K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 132K | SH | $2.97M 1.00% | 132K | 0.00 | 0.00 |
EXAGEN INCSOLE | COM | 1.04M | SH | $2.52M 0.85% | 1.04M | 0.00 | 0.00 |
ATEA PHARMACEUTICALS INCSOLE | COM | 684.51K | SH | $2.29M 0.77% | 684.51K | 0.00 | 0.00 |
SCYNEXIS INCSOLE | COM NEW | 450K | SH | $1.35M 0.45% | 450K | 0.00 | 0.00 |
CONFORMIS INCSOLE | COM NEW | 402.65K | SH | $648.3K 0.22% | 402.65K | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM | 1K | SH | $1.3K <0.01% | 1K | 0.00 | 0.00 |